Author:
Link K.H.,Kornmann M.,Bittner R.,Köckerling F.,Arbogast R.,Gastinger I.,Heitland W.,Henne-Bruns D.,Lang H.,Lippert H.,Mann M.,Meyer H.J.,Polonius M.-J.,Post S.,Raab R.,Schiedeck T.,Schumpelick V.
Publisher
Springer Science and Business Media LLC
Reference60 articles.
1. Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707–711
2. Arkenau HT, Bermann A, Rettig K et al (2003) 5-Fluorouracil plus leucovorin is an effective adjuvant chemotherapy in curatively resected stage III colon cancer: long-term follow-up results of the adjCCA-01 trial. Ann Oncol 14:395–399
3. Beckmann MW, Adler G, Albers P et al (2007) Onkologie – Dreistufenmodell optimiert Behandlung unter Kostendeckung – Wie die künftigen Strukturen der onkologischen Versorgung in Deutschland aussehen sollten. Dtsch Arztebl 104:A-3004
4. Billingsley KG, Morris AM, Dominitz JA et al (2007) Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationship. Arch Surg 142:23–31
5. Birbeck KF, Macklin CP, Tiffin NJ et al (2002) Rates of circumferential resection margin involvement vary between surgeons and predict outcomes in rectal cancer surgery. Ann Surg 235:449–457
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献